Д. А. Гусев

490 total citations
54 papers, 125 citations indexed

About

Д. А. Гусев is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, Д. А. Гусев has authored 54 papers receiving a total of 125 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 19 papers in Infectious Diseases and 18 papers in Hepatology. Recurrent topics in Д. А. Гусев's work include Hepatitis C virus research (16 papers), Liver Disease Diagnosis and Treatment (12 papers) and Hepatitis B Virus Studies (11 papers). Д. А. Гусев is often cited by papers focused on Hepatitis C virus research (16 papers), Liver Disease Diagnosis and Treatment (12 papers) and Hepatitis B Virus Studies (11 papers). Д. А. Гусев collaborates with scholars based in Russia, Germany and United States. Д. А. Гусев's co-authors include Vsevolod Zinserling, Виктор Аврутин, N. Yu. Semenova, Olga Kalinina, Т. Л. Каронова, Vadim Pokrovsky, Н Н Климко, А В Кравченко, К. В. Жданов and Yu. V. Lobzin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gut and World Journal of Gastroenterology.

In The Last Decade

Д. А. Гусев

32 papers receiving 113 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Д. А. Гусев Russia 5 65 56 22 21 11 54 125
Giovanni Cenderello Italy 5 48 0.7× 43 0.8× 14 0.6× 20 1.0× 3 0.3× 15 103
Beatriz Álvarez Spain 6 59 0.9× 31 0.6× 14 0.6× 28 1.3× 32 2.9× 18 126
Andrea Andolina Italy 7 60 0.9× 53 0.9× 5 0.2× 42 2.0× 16 1.5× 13 108
José M Miró Spain 7 109 1.7× 41 0.7× 8 0.4× 7 0.3× 46 4.2× 26 142
N Bolokadze Georgia 8 87 1.3× 94 1.7× 9 0.4× 23 1.1× 29 2.6× 22 158
Claudia Fabrizio Italy 9 134 2.1× 102 1.8× 17 0.8× 31 1.5× 51 4.6× 17 218
Margherita Sambo Italy 6 157 2.4× 29 0.5× 71 3.2× 6 0.3× 12 1.1× 20 205
J.‐C. Wasmuth Germany 7 87 1.3× 48 0.9× 8 0.4× 28 1.3× 65 5.9× 9 145
Pierluigi Blanc Italy 9 64 1.0× 119 2.1× 22 1.0× 94 4.5× 2 0.2× 18 246
Viola Guardigni Italy 6 33 0.5× 52 0.9× 3 0.1× 27 1.3× 13 1.2× 18 119

Countries citing papers authored by Д. А. Гусев

Since Specialization
Citations

This map shows the geographic impact of Д. А. Гусев's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Д. А. Гусев with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Д. А. Гусев more than expected).

Fields of papers citing papers by Д. А. Гусев

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Д. А. Гусев. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Д. А. Гусев. The network helps show where Д. А. Гусев may publish in the future.

Co-authorship network of co-authors of Д. А. Гусев

This figure shows the co-authorship network connecting the top 25 collaborators of Д. А. Гусев. A scholar is included among the top collaborators of Д. А. Гусев based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Д. А. Гусев. Д. А. Гусев is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Popenko, Anna, Artem Fadeev, Д. А. Гусев, et al.. (2024). Characterization of the upper respiratory tract microbiome of patients with acute respiratory infections by 16S rRNA sequencing. SHILAP Revista de lepidopterología. 31(4). 19–26.
2.
Гусев, Д. А., et al.. (2023). An artificial intelligence approach for prognosis of COVID-19 course in hospitalized patients. SHILAP Revista de lepidopterología. 15(3). 60–66.
3.
Хостелиди, С. Н., et al.. (2023). Invasive Candidiasis in Adult Patients with COVID-19: Results of a Multicenter Study in St. Petersburg, Russia. Journal of Fungi. 9(9). 927–927. 4 indexed citations
4.
5.
6.
Жданов, К. В., et al.. (2023). Efficacy and safety of bulevirtide in chronic hepatitis D – real life experience in Saint Petersburg. Infekcionnye bolezni. 21(1). 64–69.
7.
8.
Аврутин, Виктор, et al.. (2022). Risk of COVID-19 in newborns depending on the infection course in the mother. SHILAP Revista de lepidopterología. 1 indexed citations
9.
Жданов, К. В., et al.. (2022). Analysis of fatal outcomes of meningococcal infection in adults. Terapevticheskii arkhiv. 94(11). 1252–1256. 1 indexed citations
10.
Lobzin, Yu. V., et al.. (2022). Epidemiological patterns and features of SARS-CoV-2 on a regional, territorial scale and at the level of megacities. Sanitarnyj vrač (Sanitary Doctor). 524–539. 2 indexed citations
11.
Manikhas, Georgy M., et al.. (2022). Lung cancer and HIV. Russian Journal of Oncology. 27(5). 207–220. 1 indexed citations
12.
Bogomolov, Pavel, В. Т. Ивашкин, И. В. Маев, et al.. (2021). Efficacy and safety of bulevirtide in patients with chronic hepatitis D and compensated cirrhosis. Terapevticheskii arkhiv. 93(11). 1290–1299. 1 indexed citations
13.
Chulanov, Vladimir, Д. А. Гусев, Isakov Va, et al.. (2020). Narlaprevir, ritonavir, and sofosbuvir in non-cirrhotic chronic hepatitis C genotype 1 infected patients. 9(1). 50–56.
14.
Strunz, Benedikt, Д. А. Гусев, Björn Fischler, et al.. (2020). Evidence for B cell maturation but not trained immunity in uninfected infants exposed to hepatitis C virus. Gut. 69(12). 2203–2213. 3 indexed citations
15.
Гусев, Д. А., Isakov Va, К. В. Жданов, et al.. (2020). Efficacy and safety of 8-week combination therapy for chronic hepatitis C with protease inhibitor narlaprevir. 9(3). 41–48.
16.
Ivanov, Dmitry O., et al.. (2020). Contemporary diagnosis of HIV infection in pediatrician’s practice. Pediatrician (St Petersburg). 11(3). 73–80.
17.
Жданов, К. В., et al.. (2018). Chronic hepatitis С and non-alcoholic fatty liver disease. Main aspects of pathogenesis. Bulletin of the Russian Military Medical Academy. 20(1). 216–221. 1 indexed citations
18.
Гусев, Д. А., et al.. (2017). Cost-effectiveness of antiviral therapy in treatment-naive patients with chronic hepatitis C (genotype 1). Journal Infectology. 9(2). 101–110. 1 indexed citations
19.
20.
Жданов, К. В., et al.. (2014). Small intestinal bacterial overgrowth in patients with chronic hepatitis C. Journal Infectology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giovanni Cenderello Breakdown of academic impact, for papers by Beatriz Álvarez Breakdown of academic impact, for papers by Andrea Andolina Breakdown of academic impact, for papers by José M Miró Breakdown of academic impact, for papers by N Bolokadze Breakdown of academic impact, for papers by Claudia Fabrizio Breakdown of academic impact, for papers by Margherita Sambo Breakdown of academic impact, for papers by J.‐C. Wasmuth Breakdown of academic impact, for papers by Pierluigi Blanc Breakdown of academic impact, for papers by Viola Guardigni
Rankless by CCL
2026